nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ORM1—Erlotinib—kidney cancer	0.118	0.183	CbGbCtD
Pethidine—CYP2D6—Temsirolimus—kidney cancer	0.0653	0.101	CbGbCtD
Pethidine—CYP3A4—Everolimus—kidney cancer	0.0615	0.0952	CbGbCtD
Pethidine—ALB—Erlotinib—kidney cancer	0.0497	0.0769	CbGbCtD
Pethidine—CYP3A4—Temsirolimus—kidney cancer	0.0415	0.0643	CbGbCtD
Pethidine—CYP2B6—Sorafenib—kidney cancer	0.0412	0.0638	CbGbCtD
Pethidine—CYP2D6—Pazopanib—kidney cancer	0.0343	0.0531	CbGbCtD
Pethidine—CYP2C19—Sorafenib—kidney cancer	0.0262	0.0405	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—kidney cancer	0.025	0.0387	CbGbCtD
Pethidine—CYP2D6—Erlotinib—kidney cancer	0.0245	0.0379	CbGbCtD
Pethidine—CYP3A4—Pazopanib—kidney cancer	0.0218	0.0338	CbGbCtD
Pethidine—CYP2D6—Sorafenib—kidney cancer	0.0199	0.0308	CbGbCtD
Pethidine—CYP2D6—Vinblastine—kidney cancer	0.0197	0.0304	CbGbCtD
Pethidine—CYP3A4—Erlotinib—kidney cancer	0.0156	0.0241	CbGbCtD
Pethidine—CYP3A4—Paclitaxel—kidney cancer	0.0143	0.0221	CbGbCtD
Pethidine—CYP3A4—Sorafenib—kidney cancer	0.0127	0.0196	CbGbCtD
Pethidine—CYP3A4—Vinblastine—kidney cancer	0.0125	0.0194	CbGbCtD
Pethidine—CYP3A4—Vincristine—kidney cancer	0.0123	0.019	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—kidney cancer	0.0121	0.0187	CbGbCtD
Pethidine—CYP3A4—Sunitinib—kidney cancer	0.0103	0.0159	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—kidney cancer	0.00768	0.0119	CbGbCtD
Pethidine—Etomidate—SLC2A1—kidney cancer	0.00597	0.631	CrCbGaD
Pethidine—Ketobemidone—PTGS1—kidney cancer	0.00169	0.179	CrCbGaD
Pethidine—Cyclopentolate—BCHE—kidney cancer	0.00122	0.129	CrCbGaD
Pethidine—Levomilnacipran—ABCB1—kidney cancer	0.00058	0.0613	CrCbGaD
Pethidine—Cardiac arrest—Capecitabine—kidney cancer	0.000547	0.0027	CcSEcCtD
Pethidine—Urinary retention—Capecitabine—kidney cancer	0.000547	0.0027	CcSEcCtD
Pethidine—Somnolence—Everolimus—kidney cancer	0.000546	0.00269	CcSEcCtD
Pethidine—Dizziness—Temsirolimus—kidney cancer	0.000546	0.00269	CcSEcCtD
Pethidine—Mood swings—Capecitabine—kidney cancer	0.000545	0.00269	CcSEcCtD
Pethidine—Convulsion—Sunitinib—kidney cancer	0.000545	0.00268	CcSEcCtD
Pethidine—Dry mouth—Sorafenib—kidney cancer	0.000544	0.00268	CcSEcCtD
Pethidine—Dyskinesia—Doxorubicin—kidney cancer	0.000544	0.00268	CcSEcCtD
Pethidine—Hypertension—Sunitinib—kidney cancer	0.000543	0.00267	CcSEcCtD
Pethidine—Insomnia—Erlotinib—kidney cancer	0.000536	0.00264	CcSEcCtD
Pethidine—Decreased appetite—Vinblastine—kidney cancer	0.000536	0.00264	CcSEcCtD
Pethidine—Decreased appetite—Everolimus—kidney cancer	0.000534	0.00263	CcSEcCtD
Pethidine—Anaphylactic shock—Sorafenib—kidney cancer	0.000533	0.00263	CcSEcCtD
Pethidine—Constipation—Vinblastine—kidney cancer	0.000527	0.0026	CcSEcCtD
Pethidine—Orthostatic hypotension—Capecitabine—kidney cancer	0.000526	0.00259	CcSEcCtD
Pethidine—Constipation—Everolimus—kidney cancer	0.000525	0.00259	CcSEcCtD
Pethidine—Vomiting—Temsirolimus—kidney cancer	0.000525	0.00259	CcSEcCtD
Pethidine—Shock—Sorafenib—kidney cancer	0.000525	0.00258	CcSEcCtD
Pethidine—Dry mouth—Sunitinib—kidney cancer	0.000523	0.00258	CcSEcCtD
Pethidine—Rash—Temsirolimus—kidney cancer	0.000521	0.00257	CcSEcCtD
Pethidine—Coordination abnormal—Doxorubicin—kidney cancer	0.00052	0.00256	CcSEcCtD
Pethidine—Dermatitis—Temsirolimus—kidney cancer	0.00052	0.00256	CcSEcCtD
Pethidine—Headache—Temsirolimus—kidney cancer	0.000517	0.00255	CcSEcCtD
Pethidine—Decreased appetite—Erlotinib—kidney cancer	0.000515	0.00254	CcSEcCtD
Pethidine—Dizziness—Pazopanib—kidney cancer	0.000514	0.00253	CcSEcCtD
Pethidine—Oedema—Sunitinib—kidney cancer	0.000513	0.00253	CcSEcCtD
Pethidine—Anorexia—Sorafenib—kidney cancer	0.000508	0.0025	CcSEcCtD
Pethidine—Feeling abnormal—Vinblastine—kidney cancer	0.000508	0.0025	CcSEcCtD
Pethidine—Constipation—Erlotinib—kidney cancer	0.000507	0.0025	CcSEcCtD
Pethidine—Feeling abnormal—Everolimus—kidney cancer	0.000506	0.00249	CcSEcCtD
Pethidine—Shock—Sunitinib—kidney cancer	0.000505	0.00249	CcSEcCtD
Pethidine—Erythema—Gemcitabine—kidney cancer	0.000504	0.00249	CcSEcCtD
Pethidine—Vomiting—Pazopanib—kidney cancer	0.000495	0.00244	CcSEcCtD
Pethidine—Bradycardia—Paclitaxel—kidney cancer	0.000494	0.00243	CcSEcCtD
Pethidine—Rash—Pazopanib—kidney cancer	0.000491	0.00242	CcSEcCtD
Pethidine—Nausea—Temsirolimus—kidney cancer	0.000491	0.00242	CcSEcCtD
Pethidine—Dermatitis—Pazopanib—kidney cancer	0.00049	0.00241	CcSEcCtD
Pethidine—Anorexia—Sunitinib—kidney cancer	0.000489	0.00241	CcSEcCtD
Pethidine—Agitation—Vincristine—kidney cancer	0.000489	0.00241	CcSEcCtD
Pethidine—Headache—Pazopanib—kidney cancer	0.000487	0.0024	CcSEcCtD
Pethidine—Oedema—Dactinomycin—kidney cancer	0.000486	0.00239	CcSEcCtD
Pethidine—Vertigo—Vincristine—kidney cancer	0.000478	0.00235	CcSEcCtD
Pethidine—Visual impairment—Paclitaxel—kidney cancer	0.000468	0.0023	CcSEcCtD
Pethidine—Coma—Doxorubicin—kidney cancer	0.000467	0.0023	CcSEcCtD
Pethidine—Insomnia—Sunitinib—kidney cancer	0.000464	0.00229	CcSEcCtD
Pethidine—Decreased appetite—Sorafenib—kidney cancer	0.000464	0.00228	CcSEcCtD
Pethidine—Anorexia—Dactinomycin—kidney cancer	0.000463	0.00228	CcSEcCtD
Pethidine—Nausea—Pazopanib—kidney cancer	0.000462	0.00228	CcSEcCtD
Pethidine—Convulsion—Vincristine—kidney cancer	0.000461	0.00227	CcSEcCtD
Pethidine—Hypertension—Vincristine—kidney cancer	0.000459	0.00226	CcSEcCtD
Pethidine—Constipation—Sorafenib—kidney cancer	0.000456	0.00225	CcSEcCtD
Pethidine—Hypersensitivity—Vinblastine—kidney cancer	0.000454	0.00224	CcSEcCtD
Pethidine—Hypersensitivity—Everolimus—kidney cancer	0.000453	0.00223	CcSEcCtD
Pethidine—Flushing—Paclitaxel—kidney cancer	0.00045	0.00222	CcSEcCtD
Pethidine—Decreased appetite—Sunitinib—kidney cancer	0.000446	0.0022	CcSEcCtD
Pethidine—Asthenia—Vinblastine—kidney cancer	0.000442	0.00218	CcSEcCtD
Pethidine—Asthenia—Everolimus—kidney cancer	0.000441	0.00217	CcSEcCtD
Pethidine—Constipation—Sunitinib—kidney cancer	0.000439	0.00216	CcSEcCtD
Pethidine—Hypertension—Gemcitabine—kidney cancer	0.000436	0.00215	CcSEcCtD
Pethidine—Pruritus—Everolimus—kidney cancer	0.000435	0.00214	CcSEcCtD
Pethidine—Oedema—Vincristine—kidney cancer	0.000434	0.00214	CcSEcCtD
Pethidine—Anaphylactic shock—Vincristine—kidney cancer	0.000434	0.00214	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—kidney cancer	0.000431	0.00212	CcSEcCtD
Pethidine—Asthenia—Erlotinib—kidney cancer	0.000425	0.0021	CcSEcCtD
Pethidine—Urticaria—Sorafenib—kidney cancer	0.000424	0.00209	CcSEcCtD
Pethidine—Erythema—Paclitaxel—kidney cancer	0.000422	0.00208	CcSEcCtD
Pethidine—Decreased appetite—Dactinomycin—kidney cancer	0.000422	0.00208	CcSEcCtD
Pethidine—Hyperhidrosis—Vincristine—kidney cancer	0.00042	0.00207	CcSEcCtD
Pethidine—Pruritus—Erlotinib—kidney cancer	0.000419	0.00207	CcSEcCtD
Pethidine—Anorexia—Vincristine—kidney cancer	0.000414	0.00204	CcSEcCtD
Pethidine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000412	0.00203	CcSEcCtD
Pethidine—Oedema—Gemcitabine—kidney cancer	0.000412	0.00203	CcSEcCtD
Pethidine—Dizziness—Vinblastine—kidney cancer	0.000408	0.00201	CcSEcCtD
Pethidine—Dizziness—Everolimus—kidney cancer	0.000406	0.002	CcSEcCtD
Pethidine—Muscle spasms—Paclitaxel—kidney cancer	0.000406	0.002	CcSEcCtD
Pethidine—Hypotension—Vincristine—kidney cancer	0.000406	0.002	CcSEcCtD
Pethidine—Bradycardia—Capecitabine—kidney cancer	0.000405	0.002	CcSEcCtD
Pethidine—Feeling abnormal—Dactinomycin—kidney cancer	0.0004	0.00197	CcSEcCtD
Pethidine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000398	0.00196	CcSEcCtD
Pethidine—Tremor—Paclitaxel—kidney cancer	0.000396	0.00195	CcSEcCtD
Pethidine—Hypersensitivity—Sorafenib—kidney cancer	0.000393	0.00194	CcSEcCtD
Pethidine—Insomnia—Vincristine—kidney cancer	0.000393	0.00193	CcSEcCtD
Pethidine—Anorexia—Gemcitabine—kidney cancer	0.000392	0.00193	CcSEcCtD
Pethidine—Vomiting—Vinblastine—kidney cancer	0.000392	0.00193	CcSEcCtD
Pethidine—Dizziness—Erlotinib—kidney cancer	0.000392	0.00193	CcSEcCtD
Pethidine—Vomiting—Everolimus—kidney cancer	0.000391	0.00192	CcSEcCtD
Pethidine—Agitation—Paclitaxel—kidney cancer	0.000388	0.00191	CcSEcCtD
Pethidine—Rash—Everolimus—kidney cancer	0.000387	0.00191	CcSEcCtD
Pethidine—Dermatitis—Everolimus—kidney cancer	0.000387	0.00191	CcSEcCtD
Pethidine—Headache—Vinblastine—kidney cancer	0.000386	0.0019	CcSEcCtD
Pethidine—Headache—Everolimus—kidney cancer	0.000385	0.0019	CcSEcCtD
Pethidine—Hypotension—Gemcitabine—kidney cancer	0.000385	0.0019	CcSEcCtD
Pethidine—Visual impairment—Capecitabine—kidney cancer	0.000384	0.00189	CcSEcCtD
Pethidine—Asthenia—Sorafenib—kidney cancer	0.000383	0.00188	CcSEcCtD
Pethidine—Vertigo—Paclitaxel—kidney cancer	0.000379	0.00187	CcSEcCtD
Pethidine—Syncope—Paclitaxel—kidney cancer	0.000379	0.00187	CcSEcCtD
Pethidine—Hypersensitivity—Sunitinib—kidney cancer	0.000378	0.00186	CcSEcCtD
Pethidine—Decreased appetite—Vincristine—kidney cancer	0.000377	0.00186	CcSEcCtD
Pethidine—Pruritus—Sorafenib—kidney cancer	0.000377	0.00186	CcSEcCtD
Pethidine—Vomiting—Erlotinib—kidney cancer	0.000377	0.00186	CcSEcCtD
Pethidine—Rash—Erlotinib—kidney cancer	0.000374	0.00184	CcSEcCtD
Pethidine—Dermatitis—Erlotinib—kidney cancer	0.000373	0.00184	CcSEcCtD
Pethidine—Palpitations—Paclitaxel—kidney cancer	0.000373	0.00184	CcSEcCtD
Pethidine—Insomnia—Gemcitabine—kidney cancer	0.000372	0.00183	CcSEcCtD
Pethidine—Headache—Erlotinib—kidney cancer	0.000371	0.00183	CcSEcCtD
Pethidine—Loss of consciousness—Paclitaxel—kidney cancer	0.000371	0.00183	CcSEcCtD
Pethidine—Constipation—Vincristine—kidney cancer	0.000371	0.00183	CcSEcCtD
Pethidine—Flushing—Capecitabine—kidney cancer	0.00037	0.00182	CcSEcCtD
Pethidine—Asthenia—Sunitinib—kidney cancer	0.000368	0.00181	CcSEcCtD
Pethidine—Nausea—Vinblastine—kidney cancer	0.000366	0.0018	CcSEcCtD
Pethidine—Somnolence—Gemcitabine—kidney cancer	0.000366	0.0018	CcSEcCtD
Pethidine—Convulsion—Paclitaxel—kidney cancer	0.000366	0.0018	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—kidney cancer	0.000365	0.0018	CcSEcCtD
Pethidine—Nausea—Everolimus—kidney cancer	0.000365	0.0018	CcSEcCtD
Pethidine—Hypertension—Paclitaxel—kidney cancer	0.000365	0.0018	CcSEcCtD
Pethidine—Pruritus—Sunitinib—kidney cancer	0.000363	0.00179	CcSEcCtD
Pethidine—Anxiety—Paclitaxel—kidney cancer	0.000358	0.00177	CcSEcCtD
Pethidine—Decreased appetite—Gemcitabine—kidney cancer	0.000358	0.00176	CcSEcCtD
Pethidine—Hypersensitivity—Dactinomycin—kidney cancer	0.000358	0.00176	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—kidney cancer	0.000353	0.00174	CcSEcCtD
Pethidine—Dizziness—Sorafenib—kidney cancer	0.000353	0.00174	CcSEcCtD
Pethidine—Constipation—Gemcitabine—kidney cancer	0.000352	0.00173	CcSEcCtD
Pethidine—Nausea—Erlotinib—kidney cancer	0.000352	0.00173	CcSEcCtD
Pethidine—Dry mouth—Paclitaxel—kidney cancer	0.000352	0.00173	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—kidney cancer	0.000351	0.00173	CcSEcCtD
Pethidine—Asthenia—Dactinomycin—kidney cancer	0.000349	0.00172	CcSEcCtD
Pethidine—Confusional state—Paclitaxel—kidney cancer	0.000348	0.00171	CcSEcCtD
Pethidine—Erythema—Capecitabine—kidney cancer	0.000347	0.00171	CcSEcCtD
Pethidine—Oedema—Paclitaxel—kidney cancer	0.000345	0.0017	CcSEcCtD
Pethidine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000345	0.0017	CcSEcCtD
Pethidine—Dizziness—Sunitinib—kidney cancer	0.000339	0.00167	CcSEcCtD
Pethidine—Feeling abnormal—Gemcitabine—kidney cancer	0.000339	0.00167	CcSEcCtD
Pethidine—Shock—Paclitaxel—kidney cancer	0.000339	0.00167	CcSEcCtD
Pethidine—Vomiting—Sorafenib—kidney cancer	0.000339	0.00167	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000339	0.00167	CcSEcCtD
Pethidine—Tachycardia—Paclitaxel—kidney cancer	0.000336	0.00166	CcSEcCtD
Pethidine—Rash—Sorafenib—kidney cancer	0.000336	0.00166	CcSEcCtD
Pethidine—Dermatitis—Sorafenib—kidney cancer	0.000336	0.00165	CcSEcCtD
Pethidine—Headache—Sorafenib—kidney cancer	0.000334	0.00165	CcSEcCtD
Pethidine—Muscle spasms—Capecitabine—kidney cancer	0.000333	0.00164	CcSEcCtD
Pethidine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000333	0.00164	CcSEcCtD
Pethidine—Anorexia—Paclitaxel—kidney cancer	0.000329	0.00162	CcSEcCtD
Pethidine—Vomiting—Sunitinib—kidney cancer	0.000326	0.00161	CcSEcCtD
Pethidine—Tremor—Capecitabine—kidney cancer	0.000325	0.0016	CcSEcCtD
Pethidine—Rash—Sunitinib—kidney cancer	0.000324	0.00159	CcSEcCtD
Pethidine—Dermatitis—Sunitinib—kidney cancer	0.000323	0.00159	CcSEcCtD
Pethidine—Hypotension—Paclitaxel—kidney cancer	0.000322	0.00159	CcSEcCtD
Pethidine—Headache—Sunitinib—kidney cancer	0.000321	0.00158	CcSEcCtD
Pethidine—Hypersensitivity—Vincristine—kidney cancer	0.00032	0.00158	CcSEcCtD
Pethidine—Nausea—Sorafenib—kidney cancer	0.000317	0.00156	CcSEcCtD
Pethidine—Insomnia—Paclitaxel—kidney cancer	0.000312	0.00154	CcSEcCtD
Pethidine—Vertigo—Capecitabine—kidney cancer	0.000311	0.00153	CcSEcCtD
Pethidine—Asthenia—Vincristine—kidney cancer	0.000311	0.00153	CcSEcCtD
Pethidine—Syncope—Capecitabine—kidney cancer	0.000311	0.00153	CcSEcCtD
Pethidine—Vomiting—Dactinomycin—kidney cancer	0.000309	0.00152	CcSEcCtD
Pethidine—Somnolence—Paclitaxel—kidney cancer	0.000306	0.00151	CcSEcCtD
Pethidine—Palpitations—Capecitabine—kidney cancer	0.000306	0.00151	CcSEcCtD
Pethidine—Rash—Dactinomycin—kidney cancer	0.000306	0.00151	CcSEcCtD
Pethidine—Nausea—Sunitinib—kidney cancer	0.000305	0.0015	CcSEcCtD
Pethidine—Loss of consciousness—Capecitabine—kidney cancer	0.000305	0.0015	CcSEcCtD
Pethidine—Decreased appetite—Paclitaxel—kidney cancer	0.0003	0.00148	CcSEcCtD
Pethidine—Hypertension—Capecitabine—kidney cancer	0.000299	0.00147	CcSEcCtD
Pethidine—Asthenia—Gemcitabine—kidney cancer	0.000295	0.00146	CcSEcCtD
Pethidine—Constipation—Paclitaxel—kidney cancer	0.000295	0.00145	CcSEcCtD
Pethidine—Anxiety—Capecitabine—kidney cancer	0.000294	0.00145	CcSEcCtD
Pethidine—Pruritus—Gemcitabine—kidney cancer	0.000291	0.00144	CcSEcCtD
Pethidine—Dry mouth—Capecitabine—kidney cancer	0.000289	0.00142	CcSEcCtD
Pethidine—Nausea—Dactinomycin—kidney cancer	0.000289	0.00142	CcSEcCtD
Pethidine—Dizziness—Vincristine—kidney cancer	0.000287	0.00141	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—kidney cancer	0.000286	0.00141	CcSEcCtD
Pethidine—Confusional state—Capecitabine—kidney cancer	0.000285	0.00141	CcSEcCtD
Pethidine—Feeling abnormal—Paclitaxel—kidney cancer	0.000284	0.0014	CcSEcCtD
Pethidine—Oedema—Capecitabine—kidney cancer	0.000283	0.00139	CcSEcCtD
Pethidine—Shock—Capecitabine—kidney cancer	0.000278	0.00137	CcSEcCtD
Pethidine—Tachycardia—Capecitabine—kidney cancer	0.000276	0.00136	CcSEcCtD
Pethidine—Vomiting—Vincristine—kidney cancer	0.000276	0.00136	CcSEcCtD
Pethidine—Sweating—Doxorubicin—kidney cancer	0.000274	0.00135	CcSEcCtD
Pethidine—Urticaria—Paclitaxel—kidney cancer	0.000274	0.00135	CcSEcCtD
Pethidine—Rash—Vincristine—kidney cancer	0.000274	0.00135	CcSEcCtD
Pethidine—Hyperhidrosis—Capecitabine—kidney cancer	0.000273	0.00135	CcSEcCtD
Pethidine—Dermatitis—Vincristine—kidney cancer	0.000273	0.00135	CcSEcCtD
Pethidine—Headache—Vincristine—kidney cancer	0.000272	0.00134	CcSEcCtD
Pethidine—Anorexia—Capecitabine—kidney cancer	0.00027	0.00133	CcSEcCtD
Pethidine—Hypotension—Capecitabine—kidney cancer	0.000264	0.0013	CcSEcCtD
Pethidine—Vomiting—Gemcitabine—kidney cancer	0.000262	0.00129	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—kidney cancer	0.000261	0.00129	CcSEcCtD
Pethidine—Rash—Gemcitabine—kidney cancer	0.00026	0.00128	CcSEcCtD
Pethidine—Dermatitis—Gemcitabine—kidney cancer	0.000259	0.00128	CcSEcCtD
Pethidine—Headache—Gemcitabine—kidney cancer	0.000258	0.00127	CcSEcCtD
Pethidine—Nausea—Vincristine—kidney cancer	0.000258	0.00127	CcSEcCtD
Pethidine—Insomnia—Capecitabine—kidney cancer	0.000256	0.00126	CcSEcCtD
Pethidine—Hypersensitivity—Paclitaxel—kidney cancer	0.000254	0.00125	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—kidney cancer	0.000247	0.00122	CcSEcCtD
Pethidine—Asthenia—Paclitaxel—kidney cancer	0.000247	0.00122	CcSEcCtD
Pethidine—Decreased appetite—Capecitabine—kidney cancer	0.000246	0.00121	CcSEcCtD
Pethidine—Nausea—Gemcitabine—kidney cancer	0.000245	0.0012	CcSEcCtD
Pethidine—Pruritus—Paclitaxel—kidney cancer	0.000244	0.0012	CcSEcCtD
Pethidine—Constipation—Capecitabine—kidney cancer	0.000242	0.00119	CcSEcCtD
Pethidine—Flushing—Doxorubicin—kidney cancer	0.000238	0.00117	CcSEcCtD
Pethidine—Feeling abnormal—Capecitabine—kidney cancer	0.000233	0.00115	CcSEcCtD
Pethidine—Dizziness—Paclitaxel—kidney cancer	0.000228	0.00112	CcSEcCtD
Pethidine—Urticaria—Capecitabine—kidney cancer	0.000225	0.00111	CcSEcCtD
Pethidine—Erythema—Doxorubicin—kidney cancer	0.000223	0.0011	CcSEcCtD
Pethidine—Vomiting—Paclitaxel—kidney cancer	0.000219	0.00108	CcSEcCtD
Pethidine—Rash—Paclitaxel—kidney cancer	0.000217	0.00107	CcSEcCtD
Pethidine—Dermatitis—Paclitaxel—kidney cancer	0.000217	0.00107	CcSEcCtD
Pethidine—Headache—Paclitaxel—kidney cancer	0.000216	0.00106	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—kidney cancer	0.000215	0.00106	CcSEcCtD
Pethidine—Hypersensitivity—Capecitabine—kidney cancer	0.000208	0.00103	CcSEcCtD
Pethidine—Agitation—Doxorubicin—kidney cancer	0.000205	0.00101	CcSEcCtD
Pethidine—Nausea—Paclitaxel—kidney cancer	0.000205	0.00101	CcSEcCtD
Pethidine—Asthenia—Capecitabine—kidney cancer	0.000203	0.001	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—kidney cancer	0.000201	0.000989	CcSEcCtD
Pethidine—Syncope—Doxorubicin—kidney cancer	0.0002	0.000987	CcSEcCtD
Pethidine—Pruritus—Capecitabine—kidney cancer	0.0002	0.000986	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—kidney cancer	0.000197	0.000973	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—kidney cancer	0.000196	0.000967	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—kidney cancer	0.000194	0.000954	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—kidney cancer	0.000193	0.00095	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—kidney cancer	0.00019	0.000934	CcSEcCtD
Pethidine—Dizziness—Capecitabine—kidney cancer	0.000187	0.000922	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—kidney cancer	0.000186	0.000916	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—kidney cancer	0.000184	0.000906	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000182	0.000898	CcSEcCtD
Pethidine—Oedema—Doxorubicin—kidney cancer	0.000182	0.000898	CcSEcCtD
Pethidine—Vomiting—Capecitabine—kidney cancer	0.00018	0.000886	CcSEcCtD
Pethidine—Shock—Doxorubicin—kidney cancer	0.000179	0.000884	CcSEcCtD
Pethidine—Rash—Capecitabine—kidney cancer	0.000178	0.000879	CcSEcCtD
Pethidine—Dermatitis—Capecitabine—kidney cancer	0.000178	0.000878	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—kidney cancer	0.000178	0.000877	CcSEcCtD
Pethidine—Headache—Capecitabine—kidney cancer	0.000177	0.000873	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000176	0.000868	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—kidney cancer	0.000174	0.000856	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—kidney cancer	0.00017	0.000839	CcSEcCtD
Pethidine—Nausea—Capecitabine—kidney cancer	0.000168	0.000828	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—kidney cancer	0.000165	0.000813	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—kidney cancer	0.000162	0.000799	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—kidney cancer	0.000159	0.000781	CcSEcCtD
Pethidine—Constipation—Doxorubicin—kidney cancer	0.000156	0.000768	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—kidney cancer	0.00015	0.00074	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—kidney cancer	0.000145	0.000714	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—kidney cancer	0.000134	0.000662	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—kidney cancer	0.000131	0.000645	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—kidney cancer	0.000129	0.000636	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—kidney cancer	0.000121	0.000594	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—kidney cancer	0.000116	0.000571	CcSEcCtD
Pethidine—Rash—Doxorubicin—kidney cancer	0.000115	0.000566	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—kidney cancer	0.000115	0.000566	CcSEcCtD
Pethidine—Headache—Doxorubicin—kidney cancer	0.000114	0.000563	CcSEcCtD
Pethidine—Nausea—Doxorubicin—kidney cancer	0.000108	0.000534	CcSEcCtD
Pethidine—ALB—Metabolism—ALDH1A1—kidney cancer	3.01e-05	0.000213	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PSMD7—kidney cancer	3.01e-05	0.000213	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ANXA1—kidney cancer	3.01e-05	0.000213	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TSC1—kidney cancer	3.01e-05	0.000213	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GPC3—kidney cancer	2.99e-05	0.000212	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ACY1—kidney cancer	2.97e-05	0.00021	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IGF2—kidney cancer	2.95e-05	0.000208	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APRT—kidney cancer	2.93e-05	0.000207	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—FH—kidney cancer	2.93e-05	0.000207	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CA9—kidney cancer	2.92e-05	0.000206	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FLT1—kidney cancer	2.91e-05	0.000206	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CA2—kidney cancer	2.91e-05	0.000206	CbGpPWpGaD
Pethidine—ALB—Metabolism—PGK1—kidney cancer	2.89e-05	0.000204	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC5A3—kidney cancer	2.89e-05	0.000204	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALAD—kidney cancer	2.84e-05	0.000201	CbGpPWpGaD
Pethidine—ALB—Metabolism—LDHB—kidney cancer	2.83e-05	0.0002	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.82e-05	0.000199	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.79e-05	0.000197	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.77e-05	0.000196	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GPC3—kidney cancer	2.75e-05	0.000195	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CTNNA1—kidney cancer	2.75e-05	0.000194	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—POMC—kidney cancer	2.75e-05	0.000194	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EIF4EBP1—kidney cancer	2.74e-05	0.000193	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HSPB1—kidney cancer	2.74e-05	0.000193	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.71e-05	0.000191	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PAK1—kidney cancer	2.7e-05	0.000191	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JUNB—kidney cancer	2.7e-05	0.000191	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CA2—kidney cancer	2.68e-05	0.000189	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALAD—kidney cancer	2.61e-05	0.000184	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PGK1—kidney cancer	2.59e-05	0.000183	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.59e-05	0.000183	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.55e-05	0.00018	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—LDHB—kidney cancer	2.54e-05	0.00018	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PSMD7—kidney cancer	2.54e-05	0.00018	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ANXA1—kidney cancer	2.54e-05	0.00018	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TSC1—kidney cancer	2.54e-05	0.00018	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PDHB—kidney cancer	2.53e-05	0.000178	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—POMC—kidney cancer	2.52e-05	0.000178	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—POMC—kidney cancer	2.5e-05	0.000176	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.49e-05	0.000176	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CRABP1—kidney cancer	2.48e-05	0.000175	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.48e-05	0.000175	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.48e-05	0.000175	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FLT1—kidney cancer	2.46e-05	0.000174	CbGpPWpGaD
Pethidine—ALB—Metabolism—CA9—kidney cancer	2.46e-05	0.000174	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.4e-05	0.00017	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.4e-05	0.000169	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PGK1—kidney cancer	2.39e-05	0.000169	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.39e-05	0.000169	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CCBL1—kidney cancer	2.37e-05	0.000168	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—LDHB—kidney cancer	2.34e-05	0.000165	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—POMC—kidney cancer	2.32e-05	0.000164	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ITPR2—kidney cancer	2.31e-05	0.000163	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PAK1—kidney cancer	2.28e-05	0.000161	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JUNB—kidney cancer	2.28e-05	0.000161	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.27e-05	0.00016	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF2—kidney cancer	2.21e-05	0.000156	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CA9—kidney cancer	2.21e-05	0.000156	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN2B—kidney cancer	2.2e-05	0.000155	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.16e-05	0.000153	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.16e-05	0.000152	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF1R—kidney cancer	2.13e-05	0.000151	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—POMC—kidney cancer	2.11e-05	0.000149	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ACHE—kidney cancer	2.1e-05	0.000149	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTT1—kidney cancer	2.1e-05	0.000149	CbGpPWpGaD
Pethidine—ALB—Metabolism—CRABP1—kidney cancer	2.09e-05	0.000148	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.06e-05	0.000146	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPAT—kidney cancer	2.06e-05	0.000146	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—RAF1—kidney cancer	2.06e-05	0.000145	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—IL2—kidney cancer	2.03e-05	0.000144	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CA9—kidney cancer	2.03e-05	0.000143	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SCARB1—kidney cancer	1.99e-05	0.000141	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS1—kidney cancer	1.97e-05	0.000139	CbGpPWpGaD
Pethidine—ALB—Metabolism—ITPR2—kidney cancer	1.94e-05	0.000137	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PSMD7—kidney cancer	1.93e-05	0.000137	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—FH—kidney cancer	1.91e-05	0.000135	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APRT—kidney cancer	1.91e-05	0.000135	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CRABP1—kidney cancer	1.88e-05	0.000133	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.87e-05	0.000132	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF2—kidney cancer	1.87e-05	0.000132	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN2B—kidney cancer	1.86e-05	0.000131	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL2—kidney cancer	1.84e-05	0.00013	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—BCHE—kidney cancer	1.83e-05	0.00013	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.81e-05	0.000128	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1R—kidney cancer	1.8e-05	0.000128	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GPC3—kidney cancer	1.8e-05	0.000127	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.79e-05	0.000127	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTT1—kidney cancer	1.77e-05	0.000125	CbGpPWpGaD
Pethidine—ALB—Metabolism—ACHE—kidney cancer	1.77e-05	0.000125	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HIF1A—kidney cancer	1.76e-05	0.000124	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TSC2—kidney cancer	1.75e-05	0.000124	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CA2—kidney cancer	1.75e-05	0.000124	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.75e-05	0.000124	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ITPR2—kidney cancer	1.74e-05	0.000123	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—RAF1—kidney cancer	1.74e-05	0.000123	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.73e-05	0.000122	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—IL2—kidney cancer	1.72e-05	0.000121	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALAD—kidney cancer	1.71e-05	0.000121	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KDR—kidney cancer	1.68e-05	0.000119	CbGpPWpGaD
Pethidine—ALB—Metabolism—SCARB1—kidney cancer	1.68e-05	0.000119	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.67e-05	0.000118	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS1—kidney cancer	1.66e-05	0.000117	CbGpPWpGaD
Pethidine—ALB—Metabolism—PSMD7—kidney cancer	1.63e-05	0.000115	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.63e-05	0.000115	CbGpPWpGaD
Pethidine—ALB—Hemostasis—RAF1—kidney cancer	1.62e-05	0.000115	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.61e-05	0.000114	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.6e-05	0.000113	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ACHE—kidney cancer	1.59e-05	0.000112	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTT1—kidney cancer	1.59e-05	0.000112	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.56e-05	0.00011	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PGK1—kidney cancer	1.56e-05	0.00011	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL2—kidney cancer	1.56e-05	0.00011	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KIT—kidney cancer	1.55e-05	0.000109	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APC—kidney cancer	1.55e-05	0.000109	CbGpPWpGaD
Pethidine—ALB—Metabolism—BCHE—kidney cancer	1.54e-05	0.000109	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LDHB—kidney cancer	1.53e-05	0.000108	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC5A5—kidney cancer	1.52e-05	0.000108	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SCARB1—kidney cancer	1.51e-05	0.000106	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS1—kidney cancer	1.49e-05	0.000105	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HIF1A—kidney cancer	1.49e-05	0.000105	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—MAPK3—kidney cancer	1.48e-05	0.000105	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TSC2—kidney cancer	1.48e-05	0.000105	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—POMC—kidney cancer	1.47e-05	0.000104	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC2A1—kidney cancer	1.47e-05	0.000104	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTT1—kidney cancer	1.46e-05	0.000103	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ACHE—kidney cancer	1.46e-05	0.000103	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PSMD7—kidney cancer	1.46e-05	0.000103	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTP1—kidney cancer	1.46e-05	0.000103	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—BRAF—kidney cancer	1.46e-05	0.000103	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IL2—kidney cancer	1.45e-05	0.000103	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.43e-05	0.000101	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KDR—kidney cancer	1.42e-05	0.0001	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—MAPK1—kidney cancer	1.41e-05	9.97e-05	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.4e-05	9.92e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—BCHE—kidney cancer	1.39e-05	9.79e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SCARB1—kidney cancer	1.38e-05	9.79e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ABCB1—kidney cancer	1.38e-05	9.76e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS1—kidney cancer	1.37e-05	9.69e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.37e-05	9.67e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CA—kidney cancer	1.35e-05	9.53e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PSMD7—kidney cancer	1.34e-05	9.5e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTM1—kidney cancer	1.34e-05	9.47e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—kidney cancer	1.33e-05	9.42e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CA9—kidney cancer	1.33e-05	9.38e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.32e-05	9.34e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APC—kidney cancer	1.31e-05	9.25e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KIT—kidney cancer	1.31e-05	9.25e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.28e-05	9.06e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—BCHE—kidney cancer	1.27e-05	9.01e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.27e-05	8.98e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.26e-05	8.9e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	1.25e-05	8.86e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.25e-05	8.8e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—POMC—kidney cancer	1.25e-05	8.8e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—kidney cancer	1.24e-05	8.74e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—BRAF—kidney cancer	1.23e-05	8.69e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—kidney cancer	1.23e-05	8.68e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—kidney cancer	1.22e-05	8.65e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.22e-05	8.59e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RAF1—kidney cancer	1.22e-05	8.59e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RELA—kidney cancer	1.21e-05	8.55e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB2—kidney cancer	1.2e-05	8.5e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	1.19e-05	8.43e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MTOR—kidney cancer	1.19e-05	8.39e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MAPK3—kidney cancer	1.17e-05	8.26e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ABCB1—kidney cancer	1.16e-05	8.22e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	1.14e-05	8.05e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—kidney cancer	1.13e-05	7.98e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CRABP1—kidney cancer	1.13e-05	7.97e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—kidney cancer	1.13e-05	7.96e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.12e-05	7.9e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1B—kidney cancer	1.11e-05	7.87e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MAPK1—kidney cancer	1.11e-05	7.86e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—kidney cancer	1.1e-05	7.79e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—kidney cancer	1.09e-05	7.7e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP1A1—kidney cancer	1.07e-05	7.56e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—kidney cancer	1.06e-05	7.51e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JUN—kidney cancer	1.06e-05	7.49e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CTNNB1—kidney cancer	1.05e-05	7.43e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—kidney cancer	1.05e-05	7.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ITPR2—kidney cancer	1.05e-05	7.41e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ABCB1—kidney cancer	1.04e-05	7.37e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	1.03e-05	7.31e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RAF1—kidney cancer	1.03e-05	7.26e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—kidney cancer	1.03e-05	7.25e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RELA—kidney cancer	1.02e-05	7.23e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB2—kidney cancer	1.02e-05	7.18e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—kidney cancer	1.01e-05	7.17e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—kidney cancer	1.01e-05	7.16e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MTOR—kidney cancer	1e-05	7.09e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—kidney cancer	9.65e-06	6.82e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1A1—kidney cancer	9.6e-06	6.79e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCB1—kidney cancer	9.6e-06	6.78e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTT1—kidney cancer	9.56e-06	6.76e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ACHE—kidney cancer	9.56e-06	6.76e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—POMC—kidney cancer	9.48e-06	6.7e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	9.41e-06	6.65e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—kidney cancer	9.34e-06	6.6e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—kidney cancer	9.32e-06	6.58e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—kidney cancer	9.26e-06	6.54e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—kidney cancer	9.21e-06	6.51e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SCARB1—kidney cancer	9.05e-06	6.4e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—kidney cancer	8.98e-06	6.34e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS1—kidney cancer	8.96e-06	6.33e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JUN—kidney cancer	8.96e-06	6.33e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	8.89e-06	6.28e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1A1—kidney cancer	8.83e-06	6.24e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.79e-06	6.21e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PSMD7—kidney cancer	8.79e-06	6.21e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK3—kidney cancer	8.76e-06	6.19e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—kidney cancer	8.67e-06	6.12e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—kidney cancer	8.52e-06	6.02e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK1—kidney cancer	8.34e-06	5.89e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—BCHE—kidney cancer	8.33e-06	5.89e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.23e-06	5.82e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—POMC—kidney cancer	7.98e-06	5.64e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.95e-06	5.62e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.89e-06	5.58e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—kidney cancer	7.87e-06	5.56e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—kidney cancer	7.83e-06	5.53e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—kidney cancer	7.56e-06	5.34e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK3—kidney cancer	7.4e-06	5.23e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	7.23e-06	5.11e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—kidney cancer	7.2e-06	5.09e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—POMC—kidney cancer	7.16e-06	5.06e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK1—kidney cancer	7.04e-06	4.98e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—kidney cancer	7e-06	4.94e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—kidney cancer	6.65e-06	4.7e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—kidney cancer	6.63e-06	4.68e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—kidney cancer	6.59e-06	4.66e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—POMC—kidney cancer	6.59e-06	4.65e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—kidney cancer	6.36e-06	4.5e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCB1—kidney cancer	6.28e-06	4.43e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	6.11e-06	4.32e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—kidney cancer	6.09e-06	4.31e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—kidney cancer	5.91e-06	4.18e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.78e-06	4.08e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—kidney cancer	5.71e-06	4.04e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—kidney cancer	5.55e-06	3.92e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—kidney cancer	5.25e-06	3.71e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—kidney cancer	4.98e-06	3.52e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—kidney cancer	4.65e-06	3.29e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—kidney cancer	4.58e-06	3.24e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—POMC—kidney cancer	4.31e-06	3.04e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—kidney cancer	3.91e-06	2.77e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.51e-06	2.48e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—kidney cancer	3.43e-06	2.43e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.23e-06	2.28e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—kidney cancer	3e-06	2.12e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.11e-06	1.49e-05	CbGpPWpGaD
